Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

Articles published in
J Neurochem
    October 2022
  1. DUARTE JMN
    Serine racemase modulation for improving brain insulin resistance: An Editorial Highlight for "Deletion of serine racemase reverses neuronal insulin signaling inhibition by amyloid-beta oligomers": An Editorial Highlight for "Deletion of serine racema
    J Neurochem. 2022;163:6-7.
    >> Share

  2. ZHOU J, Zhang Z, Yang Y, Liao F, et al
    Deletion of serine racemase reverses neuronal insulin signaling inhibition by amyloid-beta oligomers.
    J Neurochem. 2022;163:8-25.
    >> Share

    September 2022
  3. VAZ M, Martins TS, Henriques AG
    Extracellular vesicles in the study of Alzheimer's and Parkinson's diseases: methodologies applied from cells to biofluids.
    J Neurochem. 2022 Sep 26. doi: 10.1111/jnc.15697.
    >> Share

  4. MICHNO W, Koutarapu S, Camacho R, Toomey C, et al
    Chemical traits of cerebral amyloid angiopathy in familial British-, Danish- and non-Alzheimer's dementias.
    J Neurochem. 2022 Sep 14. doi: 10.1111/jnc.15694.
    >> Share

    August 2022
  5. GALGANI A, Vergallo A, Campese N, Lombardo F, et al
    Biological determinants of blood-based cytokines in the Alzheimer's Disease clinical continuum.
    J Neurochem. 2022 Aug 11. doi: 10.1111/jnc.15686.
    >> Share

  6. DEVINA T, Wong YH, Hsiao CW, Li YJ, et al
    Endoplasmic reticulum stress induces Alzheimer's disease-like phenotypes in the neuron derived from the induced pluripotent stem cell with D678H mutation on amyloid precursor protein.
    J Neurochem. 2022 Aug 9. doi: 10.1111/jnc.15687.
    >> Share

  7. DI RISOLA D, Ricci D, Marrocco I, Giamogante F, et al
    ERp57 chaperon protein protects neuronal cells from Abeta-induced toxicity.
    J Neurochem. 2022;162:322-336.
    >> Share

    July 2022
  8. PEDRINI S, Doecke JD, Hone E, Wang P, et al
    Plasma high-density lipoprotein cargo is altered in Alzheimer's disease and is associated with regional brain volume.
    J Neurochem. 2022 Jul 30. doi: 10.1111/jnc.15681.
    >> Share

    May 2022
  9. QIN YR, Ma CQ, Jiang JH, Wang DP, et al
    Artesunate restores mitochondrial fusion-fission dynamics and alleviates neuronal injury in Alzheimer's disease models.
    J Neurochem. 2022 May 21. doi: 10.1111/jnc.15620.
    >> Share

  10. YU ZY, Yi X, Wang YR, Zeng GH, et al
    Inhibiting alpha1-adrenergic receptor signaling pathway ameliorates AD-type pathologies and behavioral deficits in APPswe/PS1 mouse model.
    J Neurochem. 2022;161:293-307.
    >> Share

  11. LOURENCO MV, Hausmann L
    Editorial: Honouring John Hardy - A true pioneer in research.
    J Neurochem. 2022;161:316-319.
    >> Share

    April 2022
  12. TURATI J, Rudi J, Beauquis J, Carniglia L, et al
    A metabotropic glutamate receptor 3 (mGlu3R) isoform playing neurodegenerative roles in astrocytes is prematurely up-regulated in an Alzheimer's model.
    J Neurochem. 2022 Apr 11. doi: 10.1111/jnc.15610.
    >> Share

  13. ZIFF OJ, Ashton NJ, Mehta PR, Brown R, et al
    Amyloid processing in COVID-19-associated neurological syndromes.
    J Neurochem. 2022;161:146-157.
    >> Share

    March 2022
  14. KLAFKI HW, Wirths O, Mollenhauer B, Liepold T, et al
    Detection and quantification of Abeta-3-40 (APP669-711) in cerebrospinal fluid.
    J Neurochem. 2022;160:578-589.
    >> Share

    February 2022
  15. MICHNO W, Wehrli PM, Koutarapu S, Marsching C, et al
    Structural amyloid plaque polymorphism is associated with distinct lipid accumulations revealed by trapped ion mobility mass spectrometry imaging.
    J Neurochem. 2022;160:482-498.
    >> Share

    January 2022
  16. LOPES CR, Amaral IM, Pereira MF, Lopes JP, et al
    Impact of blunting astrocyte activity on hippocampal synaptic plasticity in a mouse model of early Alzheimer's disease based on amyloid-beta peptide exposure.
    J Neurochem. 2022 Jan 19. doi: 10.1111/jnc.15575.
    >> Share

    December 2021
  17. KASICA NP, Zhou X, Yang Q, Wang X, et al
    Antagonists targeting eEF2 kinase rescue multiple aspects of pathophysiology in Alzheimer's disease model mice.
    J Neurochem. 2021 Dec 21. doi: 10.1111/jnc.15562.
    >> Share

  18. KUMAR A, Fontana IC, Nordberg A
    Reactive astrogliosis: A friend or foe in the pathogenesis of Alzheimer's disease.
    J Neurochem. 2021 Dec 20. doi: 10.1111/jnc.15565.
    >> Share

  19. FARUK MO, Tsuboi D, Yamahashi Y, Funahashi Y, et al
    Muscarinic signaling regulates voltage-gated potassium channel KCNQ2 phosphorylation in the nucleus accumbens via protein kinase C for aversive learning.
    J Neurochem. 2021 Dec 8. doi: 10.1111/jnc.15555.
    >> Share

    November 2021
  20. MA T
    Roles of eukaryotic elongation factor 2 kinase (eEF2K) in neuronal plasticity, cognition, and Alzheimer's disease.
    J Neurochem. 2021 Nov 19. doi: 10.1111/jnc.15541.
    >> Share

  21. MATUSZYK MM, Garwood CJ, Ferraiuolo L, Simpson JE, et al
    Biological and Methodological Complexities of Beta-Amyloid Peptide; Implications for Alzheimer's Disease Research.
    J Neurochem. 2021 Nov 12. doi: 10.1111/jnc.15538.
    >> Share

  22. ZULIANI G, Trentini A, Brombo G, Rosta V, et al
    Serum beta-secretase 1 (BACE1) activity increases in patients with mild cognitive impairment.
    J Neurochem. 2021;159:629-637.
    >> Share

    October 2021
  23. HANRIEDER J
    Preface: Mass spectrometry in Alzheimer disease: This is the Preface for the special issue "Mass Spectrometry in Alzheimer Disease".
    J Neurochem. 2021;159:207-210.
    >> Share

  24. GKANATSIOU E, Nilsson J, Toomey CE, Vrillon A, et al
    Amyloid pathology and synaptic loss in pathological aging.
    J Neurochem. 2021;159:258-272.
    >> Share

    September 2021
  25. JAKARIA M, Belaidi AA, Bush AI, Ayton S, et al
    Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease.
    J Neurochem. 2021 Sep 23. doi: 10.1111/jnc.15519.
    >> Share

  26. GEULA C, Dunlop SR, Ayala I, Kawles AS, et al
    Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance.
    J Neurochem. 2021;158:1394-1411.
    >> Share

    July 2021
  27. MICHNO W, Blennow K, Zetterberg H, Brinkmalm G, et al
    Refining the amyloid beta peptide and oligomer fingerprint ambiguities in Alzheimer's disease: mass spectrometric molecular characterization in brain, CSF, blood and plasma.
    J Neurochem. 2021 Jul 10. doi: 10.1111/jnc.15466.
    >> Share

  28. KORECKA M, Shaw LM
    Mass spectrometry-based methods for robust measurement of Alzheimer's Disease biomarkers in biological fluids.
    J Neurochem. 2021 Jul 10. doi: 10.1111/jnc.15465.
    >> Share


  29. Retraction: Clinical trials in Alzheimer's disease': immunotherapy approaches.
    J Neurochem. 2021 Jul 6. doi: 10.1111/jnc.15435.
    >> Share

  30. WANG XM, Zeng P, Fang YY, Zhang T, et al
    Progranulin in neurodegenerative dementia.
    J Neurochem. 2021;158:119-137.
    >> Share

  31. XU L, Tian S, Peng X, Hua Y, et al
    Clusterin inhibits Abeta42 aggregation through a "strawberry model" as detected by FRET-FCS.
    J Neurochem. 2021;158:444-454.
    >> Share

    June 2021
  32. CORTES-GOMEZ MA, Llorens-Alvarez E, Alom J, Del Ser T, et al
    Tau phosphorylation by glycogen synthase kinase 3beta modulates enzyme acetylcholinesterase expression.
    J Neurochem. 2021;157:2091-2105.
    >> Share

    May 2021
  33. LI KY, Xiang XJ, Song L, Chen J, et al
    Mitochondrial TXN2 attenuates amyloidogenesis via selective inhibition of BACE1 expression.
    J Neurochem. 2021;157:1351-1365.
    >> Share

    April 2021
  34. LEE-LIU D, Gonzalez-Billault C
    Neuron-intrinsic origin of hyperexcitability during early pathogenesis of Alzheimer's disease: An Editorial Highlight for "Hippocampal hyperactivity in a rat model of Alzheimer's disease" on https://doi.org/10.1111/jnc.15323.
    J Neurochem. 2021 Apr 28. doi: 10.1111/jnc.15248.
    >> Share

  35. SUN L, Bhawal R, Xu H, Chen H, et al
    The human brain acetylome reveals that decreased acetylation of mitochondrial proteins associates with Alzheimer's disease.
    J Neurochem. 2021 Apr 27. doi: 10.1111/jnc.15377.
    >> Share

  36. VAN DER VELPEN V, Rosenberg N, Maillard V, Teav T, et al
    Sex-specific alterations in NAD+ metabolism in triple transgenic Alzheimer's disease mouse brain assessed by quantitative targeted liquid chromatography - mass spectrometry.
    J Neurochem. 2021 Apr 8. doi: 10.1111/jnc.15362.
    >> Share

    March 2021
  37. BUTLER CA, Thornton P, Brown GC
    CD33M inhibits microglial phagocytosis, migration and proliferation, but the Alzheimer's disease-protective variant CD33m stimulates phagocytosis and proliferation, and inhibits adhesion.
    J Neurochem. 2021 Mar 15. doi: 10.1111/jnc.15349.
    >> Share

  38. CHEN H, Cross AC, Thakkar A, Xu H, et al
    Selective linkage of mitochondrial enzymes to intracellular calcium stores differs between human-induced pluripotent stem cells, neural stem cells, and neurons.
    J Neurochem. 2021;156:867-879.
    >> Share

    February 2021
  39. SOSULINA L, Mittag M, Geis HR, Hoffmann K, et al
    Hippocampal hyperactivity in a rat model of Alzheimer's disease.
    J Neurochem. 2021 Feb 14. doi: 10.1111/jnc.15323.
    >> Share

  40. ARBER C, Alatza A, Leckey CA, Paterson RW, et al
    Mass spectrometry analysis of tau and amyloid-beta in iPSC-derived models of Alzheimer's disease and dementia.
    J Neurochem. 2021 Feb 4. doi: 10.1111/jnc.15315.
    >> Share

    January 2021
  41. HUANG SJ, Ma YH, Bi YL, Shen XN, et al
    Metabolically healthy obesity and lipids may be protective factors for pathological changes of Alzheimer's disease in cognitively normal adults.
    J Neurochem. 2021 Jan 18. doi: 10.1111/jnc.15306.
    >> Share

  42. GRUNDER G, Cumming P
    Serotonin and amyloid deposition: A link between depression and Alzheimer's disease?: An Editorial Highlight on "Pimavanserin, a 5HT2A receptor inverse agonist, rapidly suppresses Abeta production and related pathology in a mouse model of Alzheimer's
    J Neurochem. 2021 Jan 18. doi: 10.1111/jnc.15269.
    >> Share

  43. HARK TJ, Savas JN
    Using stable isotope labeling to advance our understanding of Alzheimer's disease etiology and pathology.
    J Neurochem. 2021 Jan 12. doi: 10.1111/jnc.15298.
    >> Share

    December 2020
  44. HIGHET B, Anekal PV, Ryan B, Murray H, et al
    fISHing with immunohistochemistry for housekeeping gene changes in Alzheimer's disease using an automated quantitative analysis workflow.
    J Neurochem. 2020 Dec 25. doi: 10.1111/jnc.15283.
    >> Share

  45. STOLERO N, Frenkel D
    The Dialog between Neurons and Microglia in Alzheimer's Disease: The Neurotransmitters View.
    J Neurochem. 2020 Dec 12. doi: 10.1111/jnc.15262.
    >> Share

  46. YUEDE CM, Wallace CE, Davis TA, Gardiner WD, et al
    Pimavanserin, a 5HT2A receptor inverse agonist, rapidly suppresses Abeta production and related pathology in a mouse model of Alzheimer's disease.
    J Neurochem. 2020 Dec 5. doi: 10.1111/jnc.15260.
    >> Share

  47. GULYAEVA NV
    Hippocampal hyperglutamatergic signaling matters: Early targeting glutamate neurotransmission as a preventive strategy in Alzheimer's disease: An Editorial Highlight for "Riluzole attenuates glutamatergic tone and cognitive decline in AbetaPP/PS1 mice
    J Neurochem. 2020 Dec 4. doi: 10.1111/jnc.15238.
    >> Share

  48. LI W, Wu M, Zhang Y, Wei X, et al
    Intermittent fasting promotes adult hippocampal neuronal differentiation by activating GSK-3beta in 3xTg-AD mice.
    J Neurochem. 2020;155:697-713.
    >> Share

    November 2020
  49. LI L, Miao M, Chen J, Liu Z, et al
    Role of Tet2 in modulating neuronal morphology and cognition in a mouse model of Alzheimer's disease.
    J Neurochem. 2020 Nov 9. doi: 10.1111/jnc.15234.
    >> Share

  50. VINKLAROVA L, Schmidt M, Benek O, Kuca K, et al
    Friend or enemy? Review of 17beta-HSD10 and its role in human health or disease.
    J Neurochem. 2020;155:231-249.
    >> Share

    October 2020
  51. LIMEGROVER CS, LeVine H 3rd, Izzo NJ, Yurko R, et al
    Alzheimer's Protection Effect of A673T Mutation May Be Driven by Lower Abeta Oligomer Binding Affinity.
    J Neurochem. 2020 Oct 6. doi: 10.1111/jnc.15212.
    >> Share

    September 2020
  52. GAUNITZ S, Tjernberg LO, Schedin-Weiss S
    The N-glycan profile in cortex and hippocampus is altered in Alzheimer s disease.
    J Neurochem. 2020 Sep 28. doi: 10.1111/jnc.15202.
    >> Share

  53. PENA-BAUTISTA C, Alvarez L, Baquero M, Ferrer I, et al
    Plasma isoprostanoids assessment as Alzheimer Disease progression biomarkers.
    J Neurochem. 2020 Sep 12. doi: 10.1111/jnc.15183.
    >> Share

  54. PEREIRA JD, Fraga VG, Santos ALM, das Gracas Carvalho M, et al
    Alzheimer's disease and type 2 diabetes mellitus: a systematic review of proteomic studies.
    J Neurochem. 2020 Sep 9. doi: 10.1111/jnc.15166.
    >> Share

  55. BROSSERON F, Kleemann K, Kolbe CC, Santarelli F, et al
    Interrelations of Alzheimer s disease candidate biomarkers neurogranin, fatty acid binding protein 3 and ferritin to neurodegeneration and neuroinflammation.
    J Neurochem. 2020 Sep 7. doi: 10.1111/jnc.15175.
    >> Share

  56. PEDRINI S, Chatterjee P, Hone E, Martins RN, et al
    High Density Lipoprotein-related cholesterol metabolism in Alzheimer's Disease.
    J Neurochem. 2020 Sep 5. doi: 10.1111/jnc.15170.
    >> Share

    August 2020
  57. WANG L, Liu S, Xu J, Watanabe N, et al
    Emodin inhibits Abeta42 aggregation and improves cognitive deficits in Alzheimer's disease transgenic mice.
    J Neurochem. 2020 Aug 16. doi: 10.1111/jnc.15156.
    >> Share

  58. MOSSER S, Gerber H, Fraering PC
    Identification of truncated C-terminal fragments of the Alzheimer's disease amyloid protein precursor derived from sequential proteolytic pathways.
    J Neurochem. 2020 Aug 5. doi: 10.1111/jnc.15143.
    >> Share

    July 2020
  59. SIMOES-PIRES EN, Ferreira ST, Linden R
    Roles of glutamate receptors in a novel in vitro model of early, comorbid cerebrovascular and Alzheimer's diseases.
    J Neurochem. 2020 Jul 19. doi: 10.1111/jnc.15129.
    >> Share

  60. MARTINS TS, Trindade D, Vaz M, Campelo I, et al
    Diagnostic and therapeutic potential of exosomes in Alzheimer's disease.
    J Neurochem. 2020 Jul 3. doi: 10.1111/jnc.15112.
    >> Share

  61. SATHE G, Albert M, Darrow J, Saito A, et al
    Quantitative proteomic analysis of the frontal cortex in Alzheimer's disease.
    J Neurochem. 2020 Jul 2. doi: 10.1111/jnc.15116.
    >> Share

  62. GUNN AP, Wong BX, McLean C, Fowler C, et al
    Increased glutaminyl cyclase activity in brain of Alzheimer's disease individuals.
    J Neurochem. 2020 Jul 2. doi: 10.1111/jnc.15114.
    >> Share

    May 2020
  63. DE FREITAS GB, Lourenco MV, De Felice FG
    Protective actions of exercise-related FNDC5/Irisin in memory and Alzheimer's disease.
    J Neurochem. 2020 May 12. doi: 10.1111/jnc.15039.
    >> Share

  64. MUNTER LM
    The lipid component of Alzheimer's disease research: An Editorial Highlight for "Brain region-specific amyloid plaque-associated myelin lipid loss, APOE deposition and disruption of the myelin sheath in familial Alzheimer's disease mice" on https://do
    J Neurochem. 2020 May 6. doi: 10.1111/jnc.15025.
    >> Share

    April 2020
  65. FONTANA IC, Zimmer AR, Rocha AS, Gosmann G, et al
    Amyloid-beta oligomers in cellular models of Alzheimer's disease.
    J Neurochem. 2020 Apr 22. doi: 10.1111/jnc.15030.
    >> Share

  66. LI Z, Zhu H, Guo Y, Du X, et al
    Gut microbiota regulate cognitive deficits and amyloid deposition in a model of Alzheimer's disease.
    J Neurochem. 2020 Apr 22. doi: 10.1111/jnc.15031.
    >> Share

  67. BULLAIN S, Doody R
    What works and what doesn't work in Alzheimer's disease? From interventions on risk factors to anti-amyloid trials.
    J Neurochem. 2020 Apr 11. doi: 10.1111/jnc.15023.
    >> Share

    March 2020
  68. RAJAEI S, Karima S, Sepasi Tehrani H, Shateri S, et al
    Conformational Change and GTPase Activity of Human Tubulin: A Comparative Study on Alzheimer's Disease and Healthy Brain.
    J Neurochem. 2020 Mar 20. doi: 10.1111/jnc.15009.
    >> Share

  69. LI S, Selkoe DJ
    A mechanistic hypothesis for the impairment of synaptic plasticity by soluble Ab oligomers from Alzheimer brain.
    J Neurochem. 2020 Mar 17. doi: 10.1111/jnc.15007.
    >> Share

  70. LI B, Liu J, Gu G, Han X, et al
    Impact of neural stem cell-derived extracellular vesicles on mitochondrial dysfunction, sirtuin 1 level and synaptic deficits in Alzheimer's disease.
    J Neurochem. 2020 Mar 7. doi: 10.1111/jnc.15001.
    >> Share

  71. KAYA I, Jennische E, Lange S, Baykal AT, et al
    Brain Region Specific Amyloid Plaque Associated Myelin Lipid Loss, APOE Deposition and Disruption of the Myelin Sheath in Familial Alzheimer's Disease Mice.
    J Neurochem. 2020 Mar 5. doi: 10.1111/jnc.14999.
    >> Share

    February 2020
  72. HIERRO-BUJALANCE C, Del Marco A, Ramos-Rodriguez JJ, Infante-Garcia C, et al
    Cell proliferation and neurogenesis alterations in Alzheimer's disease and diabetes mellitus mixed murine models.
    J Neurochem. 2020 Feb 18. doi: 10.1111/jnc.14987.
    >> Share

    January 2020
  73. HOU TY, Zhou Y, Zhu LS, Wang X, et al
    Correcting abnormalities in miR-124/PTPN1 signaling rescues tau pathology in Alzheimer's disease.
    J Neurochem. 2020 Jan 17:e14961. doi: 10.1111/jnc.14961.
    >> Share

    November 2019
  74. IMAMURA O, Arai M, Dateki M, Oishi K, et al
    Donepezil-induced oligodendrocyte differentiation is mediated through estrogen receptors.
    J Neurochem. 2019 Nov 28. doi: 10.1111/jnc.14927.
    >> Share

    October 2019
  75. MICHNO W, Wehrli P, Meier S, Sehlin D, et al
    Chemical Imaging of Evolving Amyloid Plaque Pathology and Associated Abeta Peptide Aggregation in a Transgenic Mouse Model of Alzheimer's Disease.
    J Neurochem. 2019 Oct 12. doi: 10.1111/jnc.14888.
    >> Share

    June 2019
  76. NICHOLS MR, St-Pierre MK, Wendeln AC, Makoni NJ, et al
    Inflammatory mechanisms in neurodegeneration.
    J Neurochem. 2019;149:562-581.
    >> Share

    January 2019
  77. HASCUP ER, Broderick SO, Russell MK, Fang Y, et al
    Diet-induced insulin resistance elevates hippocampal glutamate as well as VGLUT1 and GFAP expression in AbetaPP/PS1 mice.
    J Neurochem. 2019;148:219-237.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016